An Update on PEPFAR Reauthorization
This Policy Watch provides an update on the status of PEPFAR reauthorization, which expired on March 25, 2025, allowing certain provisions to lapse.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
This Policy Watch provides an update on the status of PEPFAR reauthorization, which expired on March 25, 2025, allowing certain provisions to lapse.
Despite [Republicans’] victories, there are signs in the polling that voters are not necessarily aligned with some of the policies Republicans may pursue when it comes to health care.
Explore an overview of the Mexico City Policy, which, when in effect, requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving U.S. government global health assistance.
This data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.
To improve the affordability of abortion services, many states have passed laws that require state-regulated plans to cover the full cost of abortion services for their enrollees. This data note documents the costs associated with abortion care in private plans. Also, KFF analyzes how out of pocket spending has been affected by state laws that require full coverage of abortion services.
This brief provides information about abortion experiences, awareness, and attitudes of Florida women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
This brief provides information about abortion experiences, awareness, and attitudes of Arizona women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
This brief provides new information from the 2024 KFF Women's Health Survey about women’s experiences with abortion, the fallout of overturning Roe v. Wade, women’s knowledge about abortion laws in their states including medication abortion, as well as their opinions on the legality of abortion.
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect.
This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.
© 2025 KFF